Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1997-10-22
2000-01-11
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242291, 4242041, 4241991, 4242051, 4353201, 4352351, 536 2372, A61K 39245, A61K 3912
Patent
active
060132655
ABSTRACT:
The present invention discloses a new vaccine composition for HSV-1 and HSV-2 comprising a whole live HSV-2 virus having the oncogene deleted. Methods of using the vaccine composition are also included.
REFERENCES:
Parr et al. Labrotory Investigation. 1994, vol. 70, No. 3, pp. 369-380.
Milligan et al. Virology, 1995, vol. 206, pp. 234-241.
Murthy et al. Journal of Virology, 1989, vol. 63, No. 8, pp. 3307-3314.
Mosher Mary E.
Ramsey William S.
Salimi Ali R.
University of Maryland Baltimore
LandOfFree
Vaccine composition for herpes simplex virus and methods of usin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition for herpes simplex virus and methods of usin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition for herpes simplex virus and methods of usin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1459944